Amarin Corp Plc (AMRN)

[Whalatane]

BB
If RI fails

Lovaza / generic version ...will still be prescribed for those at risk of pancreatitis ...off label scripts ( for lowering CV risk ) will disappear

Amarins coupon plan , that saves those that use it ..about $90 each month , will end in 12/31/15 . Then Vascepa will cost those with no insurance about $8 a day ...so if no proven CV benefit I doubt STS will be using it once the coupons expire.
I certainly won't .

Interesting date 12/31/15

Coupon plan ends
Amarin about out of cash
If Vascepa shows benefit when added to Statin ..Reduce It should tells us by around then.

Mark the date : )
Kiwi